Xention Limited is a biopharmaceutical company specialized in the discovery and development of ion channel-modulating drugs.
Xention Limited, a biopharmaceutical company, specializes in the discovery and development of ion channel-modulating drugs. It offers drugs for the treatment of atrial fibrillation, overactive bladder, pain, and autoimmune diseases. Xention Limited was formerly known as Xention Discovery Ltd. and later changed its name to Xention Limited in October 2006. The company was founded in 2002 and is based in Cambridge, the United Kingdom.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 18, 2005 | Series B | €11M | 1 | — | — | Detail |
Sep 10, 2003 | Series Unknown | £4M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Albany Ventures Fund III | — | Series B |